Arvinas, Inc. (ARVN)
NASDAQ·Healthcare·Biotechnology
$8.85
+9.80%
Mkt Cap $518.11M
Analyst Ratings
Buy
9
Hold
1
Sell
0
Price Target (36 analysts)
$14.75
Range $10.00 – $20.00
Implied Upside
+66.7%
Consensus $14.75 vs current $8.85
NASDAQ·Healthcare·Biotechnology
$8.85
+9.80%
Mkt Cap $518.11M
Buy
9
Hold
1
Sell
0
Price Target (36 analysts)
$14.75
Range $10.00 – $20.00
+66.7%
Consensus $14.75 vs current $8.85